Table 1.
Characteristics of patients in care between 2011 and 2016 (N=31,346)
| N (%) | |
|---|---|
| Sex | |
| Female | 10493 (33.5) |
| Male | 20853 (66.5) |
| Age group at enrolment (years) | |
| ≤40 | 21355 (68.1) |
| 41–50 | 6742 (21.5) |
| >50 | 3249 (10.4) |
| HIV exposure category | |
| Heterosexual | 17698 (56.5) |
| MSM | 3226 (10.3) |
| IDU | 998 (3.2) |
| Other/unknown | 9424 (30.1) |
| Pre-ART HIV viral load (copies/mL) | |
| <400 | 209 (0.7) |
| 400–999 | 71 (0.2) |
| ≥1000 | 6094 (19.4) |
| Missing/not tested | 24972 (79.7) |
| Pre-ART CD4 count (cells/µL) | |
| ≥350 | 2892 (9.2) |
| 200–349 | 5665 (18.1) |
| <200 | 11620 (37.1) |
| Missing/not tested | 11169 (35.6) |
| ART initiation year | |
| ≤2010 | 13762 (43.9) |
| 2011 | 3150 (10) |
| 2012 | 2770 (8.8) |
| 2013 | 2520 (8) |
| 2014 | 1966 (6.3) |
| 2015 | 1794 (5.7) |
| 2016 | 1622 (5.2) |
| No ART started | 3762 (12) |
| HBV coinfection ^ | |
| No | 16804 (53.6) |
| Yes | 1402 (4.5) |
| Missing/not tested | 13140 (41.9) |
| HCV coinfection ^ | |
| No | 11643 (37.1) |
| Yes | 1433 (4.6) |
| Missing/not tested | 18270 (58.3) |
| Country income category | |
| Lower-middle | 25851 (89.0) |
| High | 5495 (11.0) |
MSM, men who have sex with men; IDU, injecting drug use; ART, antiretroviral therapy; HBV, hepatitis B; HCV, hepatitis C.
^
HBV and HCV coinfection based on ever having had positive HBsAg and Anti-HCV test, respectively.